Novartis Investigative Site

Hermitage, Tennessee 37076

0 studies enrolling now · 3 studies all time

What they study most

Liver Disease, Non-alcoholic Steatohepatitis (NASH)

Studies at this site

• Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis — Completed
• The Purpose of This Study is to Investigate Safety and Tolerability of Tropifexor. — Completed
• Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH) — Stopped early